Paragraph 3 Fitness information about individuals: routine and excepted applications for inclusion in a pharmaceutical list

(1)

Subject to paragraph 5, the information mentioned below in this paragraph must be included in all routine and excepted applications for inclusion in a pharmaceutical list, as regards any person (P) who is—

(a)

the individual who is making the application;

(b)

a partner in the partnership that is making the application; or

(c)

a director or (if A is seeking entry in the list mentioned in regulation 10(2)(a)) superintendent of the body corporate that is making the application.

(2)

Details of whether P—

(a)

has been convicted of any criminal offence in the United Kingdom;

(b)

has been bound over following a criminal conviction in the United Kingdom;

(c)

has accepted a police caution in the United Kingdom;

(d)

has, in summary proceedings in Scotland in respect of an offence, been the subject of an order discharging P absolutely (without proceeding to conviction); or

(e)

has accepted and agreed to pay either a procurator fiscal fine under section 302 of the Criminal Procedure (Scotland) Act 1995 M1 (fixed penalty: conditional offer by procurator fiscal) or a penalty under section 115A of the Social Security Administration Act 1992 M2 (penalty as alternative to prosecution).

(3)

Details of whether P has at any time been convicted of an offence elsewhere than in the United Kingdom where the originating events, if they took place in England (at the time of the application), could lead to a criminal conviction in England.

(4)

Details of any criminal proceedings to which P is currently subject—

(a)

in the United Kingdom; or

(b)

elsewhere than the United Kingdom if the originating events, if they took place in England, could lead to a criminal conviction in England.

(5)

If P is, to P's knowledge, or has been subject to any investigation into, or proceedings relating to, P's fitness to practise by a licensing body—

(a)

if the investigation or proceedings have not yet reached their final outcome, details of that investigation or proceedings; or

(b)

if the investigation or proceedings have reached a final outcome that was adverse, details of the final outcome of that investigation or proceedings.

(6)

If P is, to P's knowledge, or has been subject to any investigation into, or proceedings relating to, P's professional conduct by an employer—

(a)

if the investigation or proceedings have not yet reached their final outcome, details of that investigation or proceedings; or

(b)

if the investigation or proceedings have reached a final outcome that was adverse, details of the final outcome of that investigation or proceedings.

(7)

If P is a pharmacist, details of P's—

(a)

pharmaceutical qualifications (including where obtained); and

F1(b)

personal work history for the previous 7 years from the date on which the application is submitted, together with a declaration by P (where it can be made, in the case of sub-paragraphs (ii) and (iii)) that—

(i)

the details provided are a complete and accurate account of that personal work history,

(ii)

P has not been dismissed in that time, and if P cannot make this declaration, the reasons for being unable to do so must be covered in P’s personal work history,

(iii)

P has not had a break of more than 6 months from work in that time, and if P cannot make this declaration, the reasons for being unable to do so must be covered in P’s personal work history, and

(iv)

if P is an NHS chemist, or is a partner in or a director or superintendent of a NHS chemist, P or the NHS chemist in which P is a partner or of which P is a director or superintendent, has complied with the requirements of paragraph 31 of Schedule 4 and paragraph 21 of Schedule 5 that are applicable to P.

F2(8)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(9)

If P is, to P's knowledge, or has been subject to any investigation or proceedings that could lead or could have led to P's removal from a relevant list for a reason relating to unsuitability, fraud or efficiency of service provision, details of that investigation or those proceedings, and of any final outcome to that investigation or those proceedings.

(10)

If P is, to P's knowledge, or has been where the outcome was adverse, the subject of any investigation by the F3NHS CFA (or any body that preceded it which had, or outside England which has, primary responsibility for investigating fraud in the health service) in relation to fraud.

(11)

If P has been refused inclusion in, or conditionally included in, or contingently removed or suspended from, any relevant list for a reason relating to unsuitability, fraud or efficiency of service provision, details of same.

(12)

If P is in the process of applying to be included in another relevant list and proceedings relating to the application have not yet reached their final outcome (including where an application has been deferred), details of that application and the reasons for—

(a)

any deferment of that application; or

(b)

refusal or conditional inclusion where the refusal or conditional inclusion has not yet reached its final outcome.

(13)

If P—

(a)

is the person making the application; and

(b)

qualified as a pharmacist in Switzerland or an EEA State other than the United Kingdom,

details that demonstrate that P has the level of knowledge of English which, in the interests of P and the persons making use of the services to which the application relates, is necessary for the provision of those services in the area of the relevant HWB.

Annotations

Textual amendments

F1: Sch. 2 para. 3(7)(b) substituted (25.5.2023) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2023 (S.I. 2023/479), regs. 1(2), 6
F2: Sch. 2 para. 3(8) omitted (1.10.2024) by virtue of The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2024 (S.I. 2024/894), regs. 1(3), 3(2) (with reg. 3(4))
F3: Words in Sch. 2 para. 3(10) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 8(2)(a)

Marginal citations

M1: 1995 c. 46. Section 302 has been amended by: the Communications Act 2003 (c. 21), Schedule 17, paragraph 133; the Wireless Telegraphy Act 2006 (c. 36), Schedule 7, paragraph 16; the Criminal Proceedings etc. (Reform) (Scotland) Act 2007 (asp 6), section 50(1); and the Criminal Justice and Licensing (Scotland) Act 2010 (asp 13), section 70(3).
M2: 1992 c. 5. Section 115A was inserted by the Social Security Administration (Fraud) Act 1997 (c. 47), section 15, and amended by the Social Security Fraud Act 2001 (c. 11) (“the 2001 Act”), section 14. The amendments made by the 2001 Act are to be repealed by, and other amendments to section 115A are to be made by, the Welfare Reform Act 2012 (c. 5), sections 113 to 115, and Schedule 14, Part 1.